Coppell Advisory Solutions’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,765
Closed -$947K 427
2025
Q1
$947K Buy
+20,765
New +$947K 0.13% 149